Golgi Phosphoprotein 3 Represents a Novel Tumor Marker for Gastric and Colorectal Cancers

Table 1

Concentrations of serum GOLPH3, CEA, and CA19-9 in GC and CRC patients and healthy controls.

	GOLPH3 (ng/mL)	CEA (ng/mL)	CA19-9 (U/mL)
Healthy controls	2.78 (2.25-4.12)	1.48 (1.02-2.58)	9.06 (5.56-12.51)
CRC	7.67 (5.51-12.75)	4.62 (3.35-8.06)	14.47 (7.56-24.86)
GC	6.49 (5.61-7.90)	6.31 (2.54-11.90)	11.86 (8.05-21.48)

, .